Join us Thursday, July 21 at 3 pm ET for the July Therapeutics & Vaccines lab Meeting. We’ll be hearing from Elizabeth Eldridge of Health Catalyst. Liz will be describing the new research project they are taking on at the request of the Evidence Accelerator, looking at the use of dexamethasone in COVID-19 patients. 

In addition, we will be receiving an update on the Real-World Evidence Online Primer.

A third speaker will be Dr. Emily O’Brien of Duke Clinical Research Institute. Dr. O’Brien will be discussing a project she is leading under HERO, a long-term survey of COVID-19 in health care workers. The focus of her project is on the long-term safety of the Pfizer vaccine.